Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Virbac SA (V16) Stock Price & Analysis

V16 Stock Chart & Stats

€342.00-€0.50(-0.15%)
At close: 5:30 PM GMT+1
€320€330€34020 Jul10 Aug9 Sep
Day’s Range
EUR 339.00 - EUR 345.00
52-Week Range
EUR 296.00 - EUR 381.00
Previous Close
EUR 342.50
Volume
0
Average Volume (3M)
0
Market Cap
EUR 2.91B
Enterprise Value
EUR 2.98B
Total Cash (Recent Filing)
EUR 171.05M
Total Debt (Recent Filing)
EUR 359.51M
Price to Earnings (P/E)
18.7
Beta
0.41
Next Earnings
Mar 23, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
0.42%

Bulls Say, Bears Say

Bulls Say

Accelerating Revenue Growth

Steady revenue expansion, with clear acceleration in 2024–2025, indicates strengthening demand across Virbac’s animal-health portfolio. Sustained top-line growth can support ongoing investment in products and commercial reach, reinforcing the company’s earnings base over the next several quarters.

Durable Profitability

Consistently solid profitability provides evidence that Virbac converts its broad animal-health revenue base into meaningful earnings. Stable net, EBIT, and EBITDA margins support reinvestment, resilience across operating conditions, and a durable foundation for future growth.

Conservative Balance Sheet

Low-to-moderate leverage and a growing equity base give Virbac financial flexibility to fund operations and product development without relying heavily on additional borrowing. Strong mid-teens returns on equity also indicate that the expanding capital base is being used productively.

Bears Say

Moderate Cash Conversion

Positive operating and free cash flow are supportive, but the decline in free-cash-flow conversion shows that reported earnings are not translating into cash as efficiently as before. Working-capital or investment needs may therefore create volatility and limit internally funded flexibility.

Rising Leverage From Prior Lows

Although current debt-to-equity remains low to moderate, leverage has increased from exceptionally conservative prior levels. Further increases could reduce financial flexibility, raise the importance of maintaining cash generation, and leave fewer resources available for growth investment or resilience.

Limited Margin Expansion

Healthy margins remain a strength, but the absence of expansion and slight 2025 compression suggest profitability may not automatically scale with revenue. Historical gross-margin volatility also points to potential variability in cost mix or reported operating economics.

Virbac SA News

V16 FAQ

What was Virbac SA’s price range in the past 12 months?
Virbac SA lowest stock price was €296.00 and its highest was €381.00 in the past 12 months.
What is Virbac SA’s market cap?
Virbac SA’s market cap is €2.91B.
When is Virbac SA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Virbac SA’s earnings last quarter?
Virbac SA released its earnings results on Sep 17, 2026. The company reported €10.428 earnings per share for the quarter.
Is Virbac SA overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Virbac SA pay dividends?
Virbac SA does not currently pay dividends.
What is Virbac SA’s EPS estimate?
Virbac SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Virbac SA have?
Virbac SA has 8,390,660 shares outstanding.
What happened to Virbac SA’s price movement after its last earnings report?
Virbac SA reported an EPS of €10.428 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Virbac SA?
Currently, no hedge funds are holding shares in DE:V16
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology